0% commission for ETF tradesBrainstorm Cell Therapeutics Inc. Stock Forecast
AI Analysis of BCLI
| Stock Analysis |
|
| Risk Assessment |
|
| Trading Strategy |
|
Brainstorm Cell Therapeutics Inc. stock price up 4.37% on Friday
(Updated on Sep 13, 2024)
The Brainstorm Cell Therapeutics Inc. stock price gained 4.37% on the last trading day (Friday, 13th Sep 2024), rising from $0.270 to $0.282. During the last trading day the stock fluctuated 5.19% from a day low at $0.270 to a day high of $0.284. The price has fallen in 7 of the last 10 days and is down by -11.46% for this period. Volume fell on the last day by -99 thousand shares and in total, 138 thousand shares were bought and sold for approximately $38.96 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -25.91% during the next 3 months and, with a 90% probability hold a price between $0.145 and $0.257 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Have specific questions? Chat with our AI Analyst now!
BCLI Signals & Forecast
There are few to no technical positive signals at the moment. The Brainstorm Cell Therapeutics Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.309. On a fall, the stock will find some support from the short-term average at $0.274. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Monday, August 19, 2024, and so far it has fallen -26.10%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for Brainstorm Cell Therapeutics Inc. stock
On the downside, the stock finds support just below today's level from accumulated volume at $0.259 and $0.258. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Brainstorm Cell Therapeutics Inc. finds support just below today's level at $0.259. If this is broken, then the next support from accumulated volume will be at $0.258 and $0.245.
This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0140 between high and low, or 5.19%. For the last week the stock has had daily average volatility of 7.09%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (BCLI) For The Upcoming Trading Day Of Monday 16th
For the upcoming trading day on Monday, 16th we expect Brainstorm Cell Therapeutics Inc. to open at $0.279, and during the day (based on 14 day Average True Range), to move between $0.255 and $0.309, which gives a possible trading interval of +/-$0.0272 (+/-9.63%) up or down from last closing price. If Brainstorm Cell Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 19.27% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $0.259 (8.16%) than the resistance at $0.305 (8.19%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Brainstorm Cell Therapeutics Inc. stock A Buy?
Brainstorm Cell Therapeutics Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
Current score: -4.232 Sell Candidate Unchanged
Predicted Opening Price for Brainstorm Cell Therapeutics Inc. of Monday, September 16, 2024
| Fair opening price September 16, 2024 | Current price |
|---|---|
| $0.279 ( 1.18%) | $0.282 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for BCLI
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.293 | 3.78% |
| R2 | 0.287 | 1.89% |
| R1 | 0.284 | 0.714% |
| Price | 0.282 | |
| S1 | 0.273 | -3.08% |
| S2 | 0.270 | -4.25% |
| S3 | 0.265 | -6.15% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.339 | 20.04% |
| R2 | 0.336 | 19.15% |
| R1 | 0.305 | 8.19% |
| Price | 0.282 | |
| S1 | 0.259 | -8.16% |
| S2 | 0.258 | -8.69% |
| S3 | 0.245 | -13.16% |
FAQ
Click here for our free guide on how to buy Brainstorm Cell Therapeutics Inc. Stock.
